T. Chan et al., SECONDARY MYELODYSPLASTIC SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION - REPORT OF 2 CASES, Bone marrow transplantation, 13(2), 1994, pp. 145-148
We report two cases of secondary myelodysplastic syndrome (SMDS) which
followed successful treatment of a primary malignancy with high-dose
chemotherapy supported by reinfusion of autologous stem cells. The SMD
S was diagnosed 24 months and 40 months, respectively, following autog
rafting. Both patients lived for 7 months after the diagnosis of SMDS.
Our cases support the view that there is an increased risk of SMDS/ac
ute leukemia following autologous marrow transplantation.